$4.220
+0.020 (+0.48%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ARTV por análisis de gráficos similares
Alphio's ARTV stock price prediction model matches the current Artiva Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.21 (-0.20%). The 1-week path is $4.30 (+1.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Artiva Biotherapeutics Inc?
Artiva Biotherapeutics is not a good buy right now due to significant financial losses and recent downgrades by analysts. The current price is $4.19, which is near the downgraded price target of $4 from Jefferies and Wedbush. The RSI is extremely low at 12.93, indicating oversold conditions, but the company's ongoing net losses, which reached $23.5 million in Q1 2026, and the discontinuation of its lead program due to safety concerns, present substantial risks. The main risk is the potential for further declines in share price given the negative sentiment and recent analyst downgrades.
ARTV cerró en $4.22 el Wednesday, tras subir +0.48%
Artiva Biotherapeutics Inc (ARTV) last closed at $4.2199998, gaining +0.48%. These facts feed the 1-day and 1-week ARTV price prediction above.
Factores de la previsión
Los factores de la previsión de Artiva Biotherapeutics Inc (ARTV) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ARTV, ordenadas por similitud.
Análisis de estacionalidad de ARTV
Historically the probability of a positive November return for ARTV is 18.60%. June offers the highest probability of a positive month at 51.22%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ARTV
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $2.11 | $2.54 | $2.64 | -39.81% |
| Dec 2026 | $2.58 | $2.89 | $3.02 | -31.61% |
En 2026, se proyecta que Artiva Biotherapeutics Inc (ARTV) oscile entre $2.11 y $3.02.
Previsión mensual de Artiva Biotherapeutics Inc para 2026
En Nov de 2026, se proyecta que Artiva Biotherapeutics Inc promedie $2.54, con un mínimo de $2.11 y un máximo de $2.64.
En Dec de 2026, se proyecta que Artiva Biotherapeutics Inc promedie $2.89, con un mínimo de $2.58 y un máximo de $3.02.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.